Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response.

Makowsky R, Wiener HW, Ptacek TS, Silva M, Shendre A, Edberg JC, Portman MA, Shrestha S.

Pharmacogenet Genomics. 2013 Sep;23(9):455-62. doi: 10.1097/FPC.0b013e328363686e.

2.

Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.

Shrestha S, Wiener H, Shendre A, Kaslow RA, Wu J, Olson A, Bowles NE, Patel H, Edberg JC, Portman MA.

Circ Cardiovasc Genet. 2012 Jun;5(3):309-16. doi: 10.1161/CIRCGENETICS.111.962464. Epub 2012 May 7.

3.

Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.

Mamtani M, Matsubara T, Shimizu C, Furukawa S, Akagi T, Onouchi Y, Hata A, Fujino A, He W, Ahuja SK, Burns JC.

PLoS One. 2010 Jul 7;5(7):e11458. doi: 10.1371/journal.pone.0011458.

4.

High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study.

Shendre A, Wiener HW, Zhi D, Vazquez AI, Portman MA, Shrestha S.

Genes Immun. 2014 Dec;15(8):534-42. doi: 10.1038/gene.2014.47. Epub 2014 Aug 7.

5.

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.

Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.

Oncotarget. 2017 Jan 10;8(2):2044-2052. doi: 10.18632/oncotarget.13489.

6.

The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease.

Biezeveld M, Geissler J, Merkus M, Kuipers IM, Ottenkamp J, Kuijpers T.

Clin Exp Immunol. 2007 Jan;147(1):106-11.

7.

Genetic variants of CD209 associated with Kawasaki disease susceptibility.

Kuo HC, Huang YH, Chien SC, Yu HR, Hsieh KS, Hsu YW, Chang WC.

PLoS One. 2014 Aug 22;9(8):e105236. doi: 10.1371/journal.pone.0105236. eCollection 2014.

8.

[Association study of a functional SNP rs28493229 of ITPKC gene and Kawasaki disease in a Chinese population].

Peng Q, Chen CH, Wu Q, Li B, Liao J, Luo CD, Hu XP, Zheng Z, He HL, Zhang Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Dec;28(6):644-8. doi: 10.3760/cma.j.issn.1003-9406.2011.06.010. Chinese.

PMID:
22161096
9.

Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.

Kuo HC, Chang JC, Kuo HC, Yu HR, Wang CL, Lee CP, Huang LT, Yang KD.

Arthritis Rheumatol. 2015 Mar;67(3):828-36. doi: 10.1002/art.38976.

10.

[Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease].

Ji YX, Zhang HY, Lin SX.

Zhongguo Dang Dai Er Ke Za Zhi. 2013 Mar;15(3):196-200. Chinese.

11.

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.

Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, Suenaga T, Honda T, Honda A, Kobayashi H, Takeuchi T, Yoshikawa N, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Murata Y, Ebata R, Higashi K, Ozaki K, Sasago K, Tanaka T, Hata A.

Pharmacogenomics J. 2013 Feb;13(1):52-9. doi: 10.1038/tpj.2011.45. Epub 2011 Oct 11.

PMID:
21987091
12.

Expression of Fc<gamma>Rs on monocytes among Kawasaki disease patients with coronary artery lesions.

Xia Y, Tian X, Li Q, Wang G, Li C, Yang J.

Int Immunopharmacol. 2017 Apr;45:1-5. doi: 10.1016/j.intimp.2017.01.022.

PMID:
28147297
13.

Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.

Peng Q, Deng Y, Yang X, Leng X, Yang Y, Liu H.

Eur J Pediatr. 2016 May;175(5):705-13. doi: 10.1007/s00431-016-2696-8. Epub 2016 Feb 1.

PMID:
26833052
14.

Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease.

Shrestha S, Wiener HW, Olson AK, Edberg JC, Bowles NE, Patel H, Portman MA.

J Allergy Clin Immunol. 2011 Sep;128(3):677-80. doi: 10.1016/j.jaci.2011.04.027. Epub 2011 May 20. No abstract available.

15.

Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in Taiwanese children.

Lin YJ, Chang JS, Liu X, Hung CH, Lin TH, Huang SM, Jeang KT, Chen CY, Liao CC, Lin CW, Lai CH, Tien N, Lan YC, Ho MW, Chien WK, Chen JH, Huang YC, Tsang H, Wu JY, Chen CH, Chang LC, Tsai FJ.

PLoS One. 2013 Nov 22;8(11):e81384. doi: 10.1371/journal.pone.0081384. eCollection 2013.

16.

[Meta-analyses of the associations of genome-wide association study- linked gene loci with Kawasaki disease].

Peng Q, Chen CH, Wu Q, Yang Y.

Zhonghua Er Ke Za Zhi. 2013 Aug;51(8):571-7. Chinese.

PMID:
24225286
17.

Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis.

Lin L, Wang SY, Yang SB, Xiao FC.

Genet Mol Res. 2015 Jun 11;14(2):6256-64. doi: 10.4238/2015.June.9.12.

18.

[Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].

Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.

Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):891-5. Chinese.

PMID:
17254453
19.

A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.

Kuo HC, Hsu YW, Wu CM, Chen SH, Hung KS, Chang WP, Yang KD, Hsieh KS, Chen WC, Onouchi Y, Chang WC.

PLoS One. 2013 Jul 24;8(7):e69685. doi: 10.1371/journal.pone.0069685. Print 2013.

20.

Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease.

Kobayashi T, Inoue Y, Otani T, Morikawa A, Kobayashi T, Takeuchi K, Saji T, Sonobe T, Ogawa S, Miura M, Arakawa H.

Pediatr Infect Dis J. 2009 Jun;28(6):498-502.

PMID:
19504733

Supplemental Content

Support Center